1Center for Advanced Biotechnology and Departments of Physics, Biomedical Engineering, and Pharmacology and Experimental Therapeutics, Boston University, Boston, MA 02215, USA.
Researchers modified the biotin-binding site of streptavidin to change its specificity. Mutations N23A and S27D weakened biotin binding while enhancing affinity for 2-iminobiotin, demonstrating altered ligand specificity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: